The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 13, 2016
Filed:
Nov. 26, 2009
Monsef Benkirane, Saint Gely du Fesc, FR;
Robinson Triboulet, Paris, FR;
Christine Chable-bessia, Vailauques, FR;
Yamina Bennasser, Montpellier, FR;
Daniel Latreille, Montpellier, FR;
Oussama Meziane, Montpellier, FR;
Pascal Barbry, Nice, FR;
Bernard Mari, Nice, FR;
Jacques Reynes, Saint Gely du Fesc, FR;
Monsef Benkirane, Saint Gely du Fesc, FR;
Robinson Triboulet, Paris, FR;
Christine Chable-Bessia, Vailauques, FR;
Yamina Bennasser, Montpellier, FR;
Daniel Latreille, Montpellier, FR;
Oussama Meziane, Montpellier, FR;
Pascal Barbry, Nice, FR;
Bernard Mari, Nice, FR;
Jacques Reynes, Saint Gely du Fesc, FR;
Abstract
The present invention relates to at least one nucleic acid (i) comprising or consisting of or (ii) encoding a nucleic acid comprising or consisting of, a sequence selected from the group consisting of: 1) SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, and SEQ ID NO: 4, and 2) a sequence derived from SEQ ID NO: 1 to 4 by substitution deletion or insertion of at least one nucleotide, provided that a nucleic acid consisting of the sequence derived from SEQ ID NO: 1 to 4 is liable to induce HIV-1 expression in latent HIV-1-infected cells, for use as a medicament, in particular for treating retrovirus infections.